date: 2022-01-20T06:44:51Z
pdf:unmappedUnicodeCharsPerPage: 17
pdf:PDFVersion: 1.7
pdf:docinfo:title: Transcriptional Heterogeneity and the Microbiome of Cutaneous T-Cell Lymphoma
xmp:CreatorTool: LaTeX with hyperref
Keywords: cutaneous T-cell lymphoma (CTCL); mycosis fungoides (MF); Sézary syndrome (SS); transcriptome; microbiome; heterogeneity
access_permission:modify_annotations: true
access_permission:can_print_degraded: true
subject: Cutaneous T-Cell Lymphomas (CTCL) presents with substantial clinical variability and transcriptional heterogeneity. In the recent years, several studies paved the way to elucidate aetiology and pathogenesis of CTCL using sequencing methods. Several T-cell subtypes were suggested as the source of disease thereby explaining clinical and transcriptional heterogeneity of CTCL entities. Several differentially expressed pathways could explain disease progression. However, exogenous triggers in the skin microenvironment also seem to affect CTCL status. Especially Staphylococcus aureus was shown to contribute to disease progression. Only little is known about the complex microbiome patterns involved in CTCL and how microbial shifts might impact this malignancy. Nevertheless, first hints indicate that the microbiome might at least in part explain transcriptional heterogeneity and that microbial approaches could serve in diagnosis and prognosis. Shaping the microbiome could be a treatment option to maintain stable disease. Here, we review current knowledge of transcriptional heterogeneity of and microbial influences on CTCL. We discuss potential benefits of microbial applications and microbial directed therapies to aid patients with CTCL burden.
dc:creator: Philipp Licht and Volker Mailänder
dcterms:created: 2022-01-20T06:38:55Z
Last-Modified: 2022-01-20T06:44:51Z
dcterms:modified: 2022-01-20T06:44:51Z
dc:format: application/pdf; version=1.7
title: Transcriptional Heterogeneity and the Microbiome of Cutaneous T-Cell Lymphoma
Last-Save-Date: 2022-01-20T06:44:51Z
pdf:docinfo:creator_tool: LaTeX with hyperref
access_permission:fill_in_form: true
pdf:docinfo:keywords: cutaneous T-cell lymphoma (CTCL); mycosis fungoides (MF); Sézary syndrome (SS); transcriptome; microbiome; heterogeneity
pdf:docinfo:modified: 2022-01-20T06:44:51Z
meta:save-date: 2022-01-20T06:44:51Z
pdf:encrypted: false
dc:title: Transcriptional Heterogeneity and the Microbiome of Cutaneous T-Cell Lymphoma
modified: 2022-01-20T06:44:51Z
cp:subject: Cutaneous T-Cell Lymphomas (CTCL) presents with substantial clinical variability and transcriptional heterogeneity. In the recent years, several studies paved the way to elucidate aetiology and pathogenesis of CTCL using sequencing methods. Several T-cell subtypes were suggested as the source of disease thereby explaining clinical and transcriptional heterogeneity of CTCL entities. Several differentially expressed pathways could explain disease progression. However, exogenous triggers in the skin microenvironment also seem to affect CTCL status. Especially Staphylococcus aureus was shown to contribute to disease progression. Only little is known about the complex microbiome patterns involved in CTCL and how microbial shifts might impact this malignancy. Nevertheless, first hints indicate that the microbiome might at least in part explain transcriptional heterogeneity and that microbial approaches could serve in diagnosis and prognosis. Shaping the microbiome could be a treatment option to maintain stable disease. Here, we review current knowledge of transcriptional heterogeneity of and microbial influences on CTCL. We discuss potential benefits of microbial applications and microbial directed therapies to aid patients with CTCL burden.
pdf:docinfo:subject: Cutaneous T-Cell Lymphomas (CTCL) presents with substantial clinical variability and transcriptional heterogeneity. In the recent years, several studies paved the way to elucidate aetiology and pathogenesis of CTCL using sequencing methods. Several T-cell subtypes were suggested as the source of disease thereby explaining clinical and transcriptional heterogeneity of CTCL entities. Several differentially expressed pathways could explain disease progression. However, exogenous triggers in the skin microenvironment also seem to affect CTCL status. Especially Staphylococcus aureus was shown to contribute to disease progression. Only little is known about the complex microbiome patterns involved in CTCL and how microbial shifts might impact this malignancy. Nevertheless, first hints indicate that the microbiome might at least in part explain transcriptional heterogeneity and that microbial approaches could serve in diagnosis and prognosis. Shaping the microbiome could be a treatment option to maintain stable disease. Here, we review current knowledge of transcriptional heterogeneity of and microbial influences on CTCL. We discuss potential benefits of microbial applications and microbial directed therapies to aid patients with CTCL burden.
Content-Type: application/pdf
pdf:docinfo:creator: Philipp Licht and Volker Mailänder
X-Parsed-By: org.apache.tika.parser.DefaultParser
creator: Philipp Licht and Volker Mailänder
meta:author: Philipp Licht and Volker Mailänder
dc:subject: cutaneous T-cell lymphoma (CTCL); mycosis fungoides (MF); Sézary syndrome (SS); transcriptome; microbiome; heterogeneity
meta:creation-date: 2022-01-20T06:38:55Z
created: 2022-01-20T06:38:55Z
access_permission:extract_for_accessibility: true
access_permission:assemble_document: true
xmpTPg:NPages: 18
Creation-Date: 2022-01-20T06:38:55Z
pdf:charsPerPage: 3851
access_permission:extract_content: true
access_permission:can_print: true
meta:keyword: cutaneous T-cell lymphoma (CTCL); mycosis fungoides (MF); Sézary syndrome (SS); transcriptome; microbiome; heterogeneity
Author: Philipp Licht and Volker Mailänder
producer: pdfTeX-1.40.21
access_permission:can_modify: true
pdf:docinfo:producer: pdfTeX-1.40.21
pdf:docinfo:created: 2022-01-20T06:38:55Z